ArticleMolecular medicine reports2018

DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.

Wei Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.